NCT07306468 Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life
| NCT ID | NCT07306468 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Çankırı Karatekin University |
| Condition | Schizophenia Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2025-11-01 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study aims to evaluate exercise capacity, pulmonary function, respiratory muscle strength, and quality of life in individuals diagnosed with schizophrenia and bipolar disorder. These psychiatric conditions are associated with sedentary lifestyles, metabolic side effects of psychotropic medications, and increased comorbidity risks, all of which may negatively impact physical fitness and respiratory health. By assessing cardiorespiratory endurance, pulmonary parameters (FVC, FEV₁), and respiratory muscle strength in this population, the study seeks to identify physiological limitations and contribute to the development of more effective rehabilitation strategies. The findings may support multidisciplinary approaches to improving physical health and overall quality of life in individuals with severe mental illness.
Eligibility Criteria
Inclusion Criteria: * Being volunteer for participation * Being 18 to 65 age Exclusion Criteria: * Having any respiratory, cardiac, neurologic or orthopedic disease which may affect respiratory functions or exercise capacity * Having any neuropsychiatric disease except schizophrenia or bipolar disorder
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07306468 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Schizophenia Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07306468 currently recruiting?
Yes, NCT07306468 is actively recruiting participants. Contact the research team at furkanozdemir@karatekin.edu.tr for enrollment information.
Where is the NCT07306468 trial being conducted?
This trial is being conducted at Çankırı, Turkey (Türkiye).
Who is sponsoring the NCT07306468 clinical trial?
NCT07306468 is sponsored by Çankırı Karatekin University. The trial plans to enroll 150 participants.